Clinical Trial Detail

NCT ID NCT03102242
Title Atezolizumab Immunotherapy in Patients With Advanced NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: adult senior

No variant requirements are available.